{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:28:12Z","timestamp":1785338892618,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>T lymphocytes in tumor microenvironment play a pivotal role in the anti-tumor immunity, and the memory of T cells contributes to the long-term protection against tumor antigens. Compared to solid tumors, studies focusing on the T-cell differentiation in the acute myeloid leukemia (AML) bone marrow (BM) microenvironment remain limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>Fresh BM specimens collected from 103 adult AML patients at diagnosis and 12 healthy donors (HDs) were tested T-cell differentiation subsets by multi-parameter flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CD4 and CD8 T-cell compartments had different constituted profiles of T-cell differentiated subsets, which was similar between AML patients and HDs. Compared to HDs, AML patients as a whole had a significantly higher proportion of CD8 effector T cells (Teff, <jats:italic>P<\/jats:italic> = 0.048). Moreover, the T-cell compartment of AML patients with no <jats:italic>DNMT3A<\/jats:italic> mutations skewed toward terminal differentiation at the expense of memory T cells (CD4 Teff: <jats:italic>P<\/jats:italic> = 0.034; CD8 Teff: <jats:italic>P<\/jats:italic> = 0.030; CD8 memory T: <jats:italic>P<\/jats:italic> = 0.017), whereas those with mutated <jats:italic>DNMT3A<\/jats:italic> had a decrease in CD8 na\u00efve T (Tn) and CD4 effector memory T cells (Tem) as well as an increase in CD4 central memory T cells (Tcm) (<jats:italic>P<\/jats:italic> = 0.037, 0.053 and 0.053). Adverse ELN genetic risk correlated with a lower proportion of CD8 Tn. In addition, the low proportions of CD4 Tem and CD8 Tn independently predicted poorer relapse-free survival (RFS, HR [95%CI]: 5.7 (1.4\u201322.2), <jats:italic>P<\/jats:italic> = 0.017 and 4.8 [1.3\u201317.4], <jats:italic>P<\/jats:italic> = 0.013) and event-free survival (EFS, HR [95% CI]: 3.3 (1.1\u20139.5), <jats:italic>P<\/jats:italic> = 0.029; 4.0 (1.4\u201311.5), <jats:italic>P<\/jats:italic> = 0.010), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>AML patients had abnormal profiles of BM T-cell differentiation subsets at diagnosis, which was related to <jats:italic>DNMT3A<\/jats:italic> mutations. The low proportions of CD4 Tem and CD8 Tn predicted poor outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1418792","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:27:20Z","timestamp":1721363240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The profile and prognostic significance of bone marrow T-cell differentiation subsets in adult AML at diagnosis"],"prefix":"10.3389","volume":"15","author":[{"given":"Kai","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Hong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-696070","article-title":"The microenvironment in human myeloid Malignancies: emerging concepts and therapeutic implications","volume":"129","author":"Medyouf","year":"2017","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","article-title":"Human memory T cells: generation, compartmentalization and homeostasis","volume":"14","author":"Farber","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1617","article-title":"Treatment regimen, surgical outcome, and T-cell differentiation influence prognostic benefit of tumor-infiltrating lymphocytes in high-grade serous ovarian cancer","volume":"22","author":"Wouters","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S343432","article-title":"Tumor-infiltrating CD4(+) central memory T cells correlated with favorable prognosis in oral squamous cell carcinoma","volume":"15","author":"Wu","year":"2022","journal-title":"J Inflammation Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1038\/s41598-017-11122-2","article-title":"Tumor-infiltrating CD45RO(+) memory T lymphocytes predict favorable clinical outcome in solid tumors","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000334","article-title":"Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology","volume":"8","author":"Wang","year":"2020","journal-title":"J immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-018-0636-y","article-title":"Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia","volume":"11","author":"Xu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-015-0189-2","article-title":"T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment","volume":"8","author":"Schnorfeil","year":"2015","journal-title":"J Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature25144","article-title":"Effector CD8 T cells dedifferentiate into long-lived memory cells","volume":"552","author":"Youngblood","year":"2017","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nature24633","article-title":"Origin and differentiation of human memory CD8 T cells after vaccination","volume":"552","author":"Akondy","year":"2017","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"New Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33461","article-title":"Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones","volume":"148","author":"Saeed","year":"2021","journal-title":"Int J cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-017-0414-2","article-title":"The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia","volume":"10","author":"Qin","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13864","article-title":"Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype","volume":"44","author":"Xu","year":"2022","journal-title":"Int J Lab hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16526","article-title":"Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)","volume":"190","author":"Zhou","year":"2020","journal-title":"Br J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0591-8","article-title":"Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia","volume":"88","author":"Ruan","year":"2009","journal-title":"Ann Hematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","article-title":"The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update","volume":"14","author":"Zhang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nprot.2012.143","article-title":"Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells","volume":"8","author":"Lugli","year":"2013","journal-title":"Nat Protoc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999163","article-title":"Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse","volume":"13","author":"Odak","year":"2022","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41467-019-08871-1","article-title":"Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT","volume":"10","author":"Noviello","year":"2019","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483487","article-title":"A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells","volume":"122","author":"Kim","year":"2013","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"New Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-461624","article-title":"Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)","volume":"121","author":"Gaidzik","year":"2013","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.85","article-title":"Loss of Dnmt3a and endogenous Kras(G12D\/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis","volume":"29","author":"Chang","year":"2015","journal-title":"Leukemia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1324297111","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"149ra18","DOI":"10.1126\/scitranslmed.3004315","article-title":"Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia","volume":"4","author":"Jan","year":"2012","journal-title":"Sci Trans Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cas.15195","article-title":"Circulating na\u00efve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma","volume":"113","author":"Takahashi","year":"2022","journal-title":"Cancer science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00973-w","article-title":"Effector memory cytotoxic CD3(+)\/CD8(+)\/CD45RO(+) T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancer","volume":"35","author":"Sun","year":"2022","journal-title":"Modern Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1038\/s41467-022-34467-3","article-title":"GZMK(high) CD8(+) T effector memory cells are associated with CD15(high) neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome","volume":"13","author":"Tiberti","year":"2022","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1916206117","article-title":"Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia","volume":"117","author":"Lamble","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.996348","article-title":"Clinical predictive value of na\u00efve and memory T cells in advanced NSCLC","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29854","article-title":"Patient-individualized CD8+ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice","volume":"138","author":"Distler","year":"2016","journal-title":"Int J cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1418792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:27:23Z","timestamp":1721363243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1418792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2024.1418792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1418792","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"1418792"}}